nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
|
Tseng, Ling-Ming |
|
2017 |
163 |
2 |
p. 241-254 |
artikel |
2 |
Basal markers and prognosis in luminal breast cancer
|
Engstrøm, Monica J. |
|
2017 |
163 |
2 |
p. 207-217 |
artikel |
3 |
Breast cancer screening in patients with cancers other than breast
|
Leopold, Robin B. |
|
2017 |
163 |
2 |
p. 343-348 |
artikel |
4 |
Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
|
Roberts, Megan C. |
|
2017 |
163 |
2 |
p. 303-310 |
artikel |
5 |
Breast cancer subtype distribution is different in normal weight, overweight, and obese women
|
Gershuni, Victoria |
|
2017 |
163 |
2 |
p. 375-381 |
artikel |
6 |
Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study
|
Conway, Kathleen |
|
2017 |
163 |
2 |
p. 349-361 |
artikel |
7 |
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing
|
Yanagawa, Takehiro |
|
2017 |
163 |
2 |
p. 231-240 |
artikel |
8 |
Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control
|
Bourke, M. |
|
2017 |
163 |
2 |
p. 403-405 |
artikel |
9 |
Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer
|
Park, Hyung Soon |
|
2017 |
163 |
2 |
p. 255-262 |
artikel |
10 |
Estrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women
|
Kjartansdottir, Olof J. |
|
2017 |
163 |
2 |
p. 363-373 |
artikel |
11 |
Evaluation of changes to foot shape in females 5 years after mastectomy: a case–control study
|
Głowacka-Mrotek, Iwona |
|
2017 |
163 |
2 |
p. 287-294 |
artikel |
12 |
Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC)
|
Vadaparampil, Susan T. |
|
2017 |
163 |
2 |
p. 331-342 |
artikel |
13 |
Identification of frequent somatic mutations in inflammatory breast cancer
|
Matsuda, Naoko |
|
2017 |
163 |
2 |
p. 263-272 |
artikel |
14 |
Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer
|
Salgado, Teresa M. |
|
2017 |
163 |
2 |
p. 311-319 |
artikel |
15 |
Lymphatico-venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life
|
Cornelissen, Anouk J. M. |
|
2017 |
163 |
2 |
p. 281-286 |
artikel |
16 |
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients
|
Crawford, Beth |
|
2017 |
163 |
2 |
p. 383-390 |
artikel |
17 |
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
|
Bingham, Catherine |
|
2017 |
163 |
2 |
p. 219-230 |
artikel |
18 |
Oncoplastic surgery with omental flap reconstruction: a study of 200 cases
|
Munhoz, Alexandre Mendonça |
|
2017 |
163 |
2 |
p. 407-409 |
artikel |
19 |
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities
|
Rauscher, Garth H. |
|
2017 |
163 |
2 |
p. 321-330 |
artikel |
20 |
Reply to Munhoz et al.
|
Zaha, Hisamitsu |
|
2017 |
163 |
2 |
p. 411-412 |
artikel |
21 |
Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis
|
Rugo, Hope S. |
|
2017 |
163 |
2 |
p. 199-205 |
artikel |
22 |
The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy
|
Rojas, K. |
|
2017 |
163 |
2 |
p. 273-279 |
artikel |
23 |
Treatment of cutaneous metastases of breast cancer with electrochemotherapy: what is the magnitude of clinical benefit?
|
Campana, Luca G. |
|
2017 |
163 |
2 |
p. 399-401 |
artikel |
24 |
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
|
Dieci, M. V. |
|
2017 |
163 |
2 |
p. 295-302 |
artikel |
25 |
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)
|
Kimmick, Gretchen G. |
|
2017 |
163 |
2 |
p. 391-398 |
artikel |